Anchored in Boston, the intellectual property transactions team at Ropes & Gray LLP is well-equipped to handle licensing and commercial transactions and agreements on behalf of some of the largest technology and life sciences companies, while considering individual clients’ goals and addressing industry-specific risks. David McIntosh leads the intellectual property transaction group from the firm’s headquarters and advises life science companies and investors in technology licensing, strategic collaborations, and corporate transactions. Supporting McIntosh from the Boston office are Edward Black, who represents technology, media, and telecommunications clients in strategic asset management and licensing, and Hannah England, who focuses on asset acquisitions, licensing transactions, and commercialization agreements on behalf of sophisticated clients across the life sciences industry.
Legal 500 Editorial commentary

Accolades

Client satisfaction: Lawyer & team quality

Key clients

  • Bain Capital, P
  • Sarepta Therapeutics, Inc.
  • Shire Plc
  • Sana Biotechnology, Inc.
  • Domino's Pizza, Inc.
  • Blueprint Medicines Corporation
  • Altius Institute for Biomedical Sciences
  • The Independent Transactions Committee of the Board of Directors of Akcea Therapeutics
  • M/A-COM Technology Solutions Holdings Inc.
  • Pfizer Inc.
  • CANbridgepharma Limited
  • Juno Therapeutics, Inc.
  • Pacific Investment Management Company LLC
  • TPG Capital, L.P.
  • TSG Consumer Partners
  • Selecta Biosciences, Inc.
  • Los Angeles Biomedical Research Institute
  • Lyell Immunopharma, Inc.

Lawyers

Leading partners

The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.

Next Generation Partners

Junior partners with significant recognition from clients and peers in the market and key roles on multiple matters.

Practice head

David McIntosh

Other key lawyers

Edward Black; Hannah England; Mark Bellomy; Megan Baca; Marc Rubenstein